 BOSTON and LAUSANNE, Switzerland, April 13, 2022 GLOBE NEWSWIRE -- SOPHiA GENETICS SA Nasdaq: SOPH, a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal 2022 before U.S. markets open on Tuesday, May 10, 2022. SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:30 a.m. Eastern Time 2:30 p.m. Central European Time. 